X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (211916) 211916
Book Chapter (859) 859
Dissertation (351) 351
Magazine Article (284) 284
Book / eBook (144) 144
Conference Proceeding (126) 126
Publication (126) 126
Newsletter (106) 106
Web Resource (65) 65
Book Review (58) 58
Reference (33) 33
Government Document (17) 17
Journal / eJournal (16) 16
Newspaper Article (14) 14
Streaming Video (10) 10
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (113929) 113929
humans (88897) 88897
male (78610) 78610
rats (54555) 54555
female (46821) 46821
pharmacology & pharmacy (39719) 39719
neurosciences (36218) 36218
mice (31385) 31385
dose-response relationship, drug (23701) 23701
adult (20337) 20337
rats, sprague-dawley (20235) 20235
biochemistry & molecular biology (17962) 17962
agonists (17484) 17484
middle aged (16686) 16686
agonist (15877) 15877
rats, wistar (14366) 14366
in vitro techniques (13306) 13306
expression (12785) 12785
cells, cultured (12564) 12564
activation (12483) 12483
ligands (11815) 11815
receptors (11543) 11543
time factors (11335) 11335
aged (10396) 10396
rat (10179) 10179
physiology (9477) 9477
adrenergic beta-agonists - pharmacology (9445) 9445
brain (9396) 9396
endocrinology & metabolism (9355) 9355
analysis (9154) 9154
chemistry, medicinal (9068) 9068
mice, inbred c57bl (8836) 8836
psychiatry (8781) 8781
treatment outcome (8540) 8540
cell biology (8459) 8459
research (8427) 8427
disease models, animal (8417) 8417
receptor (8301) 8301
neurons (8287) 8287
cell line (8049) 8049
clinical neurology (7954) 7954
adrenergic alpha-agonists - pharmacology (7653) 7653
signal transduction (7543) 7543
dopamine (7458) 7458
neurons - drug effects (7437) 7437
structure-activity relationship (7227) 7227
physiological aspects (6913) 6913
calcium - metabolism (6803) 6803
inhibition (6669) 6669
cells (6654) 6654
immunology (6621) 6621
binding (6594) 6594
adolescent (6116) 6116
pharmacology (6089) 6089
inflammation (6083) 6083
signal transduction - drug effects (6067) 6067
apoptosis (5885) 5885
serotonin receptor agonists - pharmacology (5794) 5794
double-blind method (5648) 5648
pregnancy (5586) 5586
phosphorylation (5584) 5584
proteins (5531) 5531
dopamine agonists - pharmacology (5375) 5375
in-vitro (5345) 5345
double-blind (5344) 5344
isoproterenol - pharmacology (5227) 5227
excitatory amino acid agonists - pharmacology (5224) 5224
mice, knockout (5217) 5217
serotonin (5173) 5173
care and treatment (5162) 5162
drug interactions (5109) 5109
health aspects (5045) 5045
antagonists (5034) 5034
kinetics (4983) 4983
behavior, animal - drug effects (4971) 4971
neurons - metabolism (4923) 4923
multidisciplinary sciences (4904) 4904
antagonist (4870) 4870
asthma (4838) 4838
in-vivo (4806) 4806
cardiac & cardiovascular systems (4774) 4774
blood pressure - drug effects (4754) 4754
rodents (4743) 4743
asthma - drug therapy (4686) 4686
adrenergic beta-agonists - therapeutic use (4673) 4673
motor activity - drug effects (4637) 4637
medicine, research & experimental (4636) 4636
brain - metabolism (4574) 4574
gene expression (4546) 4546
neurology (4513) 4513
drug therapy (4476) 4476
cell line, tumor (4475) 4475
binding sites (4471) 4471
analysis of variance (4454) 4454
respiratory system (4446) 4446
oncology (4418) 4418
chemistry, organic (4417) 4417
patch-clamp techniques (4329) 4329
amino acid sequence (4294) 4294
molecular sequence data (4288) 4288
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (105) 105
Online Resources - Online (60) 60
UofT at Mississauga - Stacks (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (10) 10
Gerstein Science - Periodical Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
UTL at Downsview - May be requested (6) 6
UofT at Scarborough - Stacks (6) 6
Gerstein Science - Bindery (4) 4
New College (Ivey) - Stacks (2) 2
Robarts - Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
St. Michael's Hospital - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Theses (1) 1
OISE - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (207482) 207482
Japanese (2628) 2628
German (1862) 1862
French (1567) 1567
Russian (1382) 1382
Chinese (698) 698
Spanish (566) 566
Portuguese (516) 516
Polish (280) 280
Italian (158) 158
Korean (148) 148
Czech (99) 99
Hungarian (97) 97
Danish (90) 90
Dutch (85) 85
Swedish (81) 81
Ukrainian (73) 73
Norwegian (59) 59
Turkish (49) 49
Bulgarian (34) 34
Finnish (23) 23
Slovak (23) 23
Hebrew (21) 21
Romanian (20) 20
Serbian (16) 16
Lithuanian (13) 13
Slovenian (9) 9
Persian (8) 8
Croatian (6) 6
Arabic (4) 4
Icelandic (3) 3
Afrikaans (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2008, Progress in brain research, ISBN 0444532358, Volume 172., xv, 665 p. [6] p. of plates
This book provides a unique and timely multidisciplinary synthesis of our current knowledge of the anatomy, pharmacology, physiology and behavioral data of the... 
Neurochemistry | Neurotransmitters | Dopamine | Serotonin
Book
1997, Lung biology in health and disease, ISBN 9780824794965, Volume 106., xvi, 443
Book
2010, ISBN 9780313382802, xiv, 238
Book
Frontiers in neuroscience, ISSN 1662-453X, 2015, Volume 9, p. 125
Background: Application of transcranial random noise stimulation (tRNS) between 0.1 and 640 Hz of the primary motor cortex (M1) for 10 min induces a persistent... 
Transcranial magnetic stimulation (TMS) | D-cycloserine (D-CYC: partial NMDA receptor agonist) | Dextromethorphan (DMO: NMDA receptor antagonist) | transcranial random noise stimulation (tRNS) | Carbamazepine (CBZ: sodium channel blocker) | Lorazepam (LOR: GABA A receptor agonist) | Ropinirole (ROP: D 2 /D 3 receptor agonist) | Transcranial direct current stimulation (tDCS) | carbamazepine (CBZ: sodium channel blocker) | CELLS | ACTIVATION | EXCITATION | NEUROPLASTICITY | HUMANS | NEUROSCIENCES | CORTICAL EXCITABILITY | HUMAN MOTOR CORTEX | CONSOLIDATION | ropinirole (ROP: D-2/D-3 receptor agonist) | transcranial magnetic stimulation (TMS) | NONINVASIVE BRAIN-STIMULATION | dextromethorphan (DMO: NMDA receptor antagonist) | transcranial direct current stimulation (tDCS) | MODULATION | lorazepam (LOR: GABA(A) receptor agonist) | Transcranial magnetic stimulation | Dopamine | γ-Aminobutyric acid A receptors | Glutamic acid receptors (ionotropic) | Noise | Cortex | Dopamine D3 receptors | Excitability | N-Methyl-D-aspartic acid receptors | Dextromethorphan | Cortex (motor) | Cycloserine | Benzodiazepines | Carbamazepine | Neurophysiology | Electrical currents | Electrodes | Morphology | Lorazepam | Agonists | Magnetic fields | Electric fields | ropinirole (ROP: D2/D3 receptor agonist) | lorazepam (LOR: GABAA receptor agonist)
Journal Article
Bioorganic & medicinal chemistry letters, ISSN 0960-894X, 09/2013, Volume 23, Issue 18, pp. 5082 - 5085
Journal Article
Biological psychiatry (1969), ISSN 0006-3223, 2017, Volume 81, Issue 1, pp. 67 - 77
Journal Article
Neuropharmacology, ISSN 0028-3908, 10/2012, Volume 63, Issue 5, pp. 905 - 915
Mu-opioid and CB1-cannabinoid agonists produce analgesia; however, adverse effects limit use of drugs in both classes. Additive or synergistic effects... 
Analgesia | Morphine | Marijuana | G-protein | Adenylyl cyclase | CB1 receptors | AGONIST MORPHINE | ACTIVATION | PROTEIN-KINASE | CB1 CANNABINOID RECEPTOR | SYNERGISTIC INTERACTIONS | NEUROSCIENCES | INHIBITION | KAPPA | FULL AGONIST | ADENYLYL-CYCLASE | PHARMACOLOGY & PHARMACY | RAT-BRAIN | Pyrazoles - therapeutic use | Receptor, Cannabinoid, CB2 - agonists | Humans | Analgesics, Opioid - pharmacology | Receptors, Opioid, mu - agonists | Piperidines - pharmacology | Cannabinoid Receptor Agonists - therapeutic use | Recombinant Proteins - antagonists & inhibitors | Piperidines - metabolism | Receptors, Opioid, mu - metabolism | Morpholines - metabolism | Analgesics, Non-Narcotic - metabolism | Drug Inverse Agonism | Mice | Analgesics, Opioid - metabolism | Kinetics | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Analgesics, Opioid - antagonists & inhibitors | Cannabinoid Receptor Agonists - metabolism | Cricetulus | Analgesics, Non-Narcotic - pharmacology | Cannabinoid Receptor Agonists - pharmacology | Receptor, Cannabinoid, CB2 - genetics | Analgesics, Opioid - adverse effects | Narcotic Antagonists - metabolism | Receptor, Cannabinoid, CB1 - agonists | Analgesics, Non-Narcotic - adverse effects | Cannabinoid Receptor Agonists - adverse effects | Morpholines - adverse effects | CHO Cells | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Binding, Competitive | Recombinant Proteins - metabolism | Cricetinae | Morpholines - pharmacology | Narcotic Antagonists - adverse effects | Recombinant Proteins - agonists | Analgesics, Non-Narcotic - therapeutic use | Pyrazoles - metabolism | Mice, Inbred Strains | Receptors, Opioid, mu - antagonists & inhibitors | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Animals | Narcotic Antagonists - therapeutic use | Piperidines - therapeutic use | Narcotic Antagonists - pharmacology | Piperidines - adverse effects | Receptors, Opioid, mu - genetics | Index Medicus | Drugs | Pain perception | Opioid receptors | Cyclic AMP | Opioid receptors (type mu) | Antagonists | Cannabinoid CB1 receptors | Guanine nucleotide-binding protein | Antagonism | Cell activation | Side effects | Inverse agonists | CB1 Receptors | Adenylyl Cyclase
Journal Article
Neuropharmacology, ISSN 0028-3908, 2016, Volume 104, pp. 31 - 49
Pharmacological tool compounds are now available to define action at the adenosine (ARs), P2Y and P2X receptors. We present a selection of the most commonly... 
Nucleosides | GPCR | Agonists | Antagonists | Nucleotides | Ion channel | ATP | PROTEIN-COUPLED RECEPTORS | ALLOSTERIC MODULATION | NEUROSCIENCES | NEUROPATHIC PAIN | NUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE | IN-VIVO | ION-CHANNEL | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | PURINERGIC RECEPTOR | P2Y RECEPTOR | STRUCTURE-BASED DESIGN | Purinergic P1 Receptor Agonists - chemistry | Receptors, Purinergic P2Y - chemistry | Receptors, Purinergic P2X - chemistry | Humans | Purinergic P1 Receptor Agonists - pharmacology | Receptors, Purinergic P2Y - metabolism | Purinergic P1 Receptor Antagonists - therapeutic use | Purinergic P2Y Receptor Agonists - chemistry | Purinergic P2Y Receptor Agonists - therapeutic use | Structure-Activity Relationship | Purinergic P1 Receptor Agonists - therapeutic use | Chemistry, Pharmaceutical | Purinergic P1 Receptor Antagonists - pharmacology | Purinergic P2Y Receptor Agonists - pharmacology | Receptors, Purinergic P1 - chemistry | Animals | Purinergic Agents - chemistry | Purinergic Agents - therapeutic use | Receptors, Purinergic P2X - metabolism | Receptors, Purinergic P1 - metabolism | Purinergic Agents - pharmacology | Purinergic P1 Receptor Antagonists - chemistry | Prevention | Brain | Purines | Enzymes | Injuries | Chronic pain | Cancer | antagonists | nucleosides | agonists | ion channel | nucleotides
Journal Article
Philosophical transactions. Biological sciences, ISSN 1471-2970, 2012, Volume 367, Issue 1607, pp. 3353 - 3363
Human tissues express cannabinoid CB₁ and CB₂ receptors that can be activated by endogenously released 'endocannabinoids' or exogenously administered compounds... 
Receptors | Cannabinoids | Animal models | Pain | Medical treatment | Agonists | Morphine | Drug design | Endocannabinoids | Cannabinoid receptors | health and disease and epidemiology | Articles | And CB2 | Blood-brain barrier | Cannabinoid receptor agonists | Δ9-tetrahydrocannabinol | Cannabinoid CB1 | Therapeutic applications and strategies | blood-brain barrier | Delta-tetrahydrocannabinol | cannabinoid CB1 and CB2 receptors | CB2 RECEPTOR | LIVER-DISEASES | AMYOTROPHIC-LATERAL-SCLEROSIS | ANXIETY-LIKE BEHAVIOR | MU-OPIOID RECEPTOR | RAT FORMALIN TEST | therapeutic applications and strategies | cannabinoid receptor agonists | NEUROPATHIC PAIN | MOUSE MODEL | BIOLOGY | PENTYLENETETRAZOLE-INDUCED SEIZURE | CENTRAL-NERVOUS-SYSTEM | Endocannabinoids - metabolism | Analgesics - pharmacology | Receptor, Cannabinoid, CB2 - agonists | Cardiovascular Diseases - drug therapy | Humans | Cannabinoid Receptor Agonists - pharmacology | Neurodegenerative Diseases - drug therapy | Pain - metabolism | Receptor, Cannabinoid, CB1 - agonists | Pain - drug therapy | Cannabinoid Receptor Agonists - therapeutic use | Dronabinol - pharmacology | Analgesics - therapeutic use | Cardiovascular Diseases - metabolism | Risk Assessment | Analgesics - administration & dosage | Clinical Trials as Topic | Neurodegenerative Diseases - metabolism | Blood-Brain Barrier - drug effects | Cannabinoid Receptor Agonists - administration & dosage | Drug Discovery | Blood-Brain Barrier - metabolism | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Animals | Dronabinol - therapeutic use | Review
Journal Article
European Urology, ISSN 0302-2838, 2012, Volume 63, Issue 2, pp. 283 - 295
Abstract Background Mirabegron, a β3 -adrenoceptor agonist, has been developed for the treatment of overactive bladder (OAB). Objective To assess the efficacy... 
Urology | Mirabegron | β3-Adrenoceptor agonist | Overactive bladder (OAB) | Adrenoceptor agonist
Journal Article